Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
214 Cards in this Set
- Front
- Back
|
Stage I Rectal Adenocarcinoma
|
T1 N0 or T2 N0.
|
|
|
Stage II rectal adenocarcinoma
|
IIA. T3 N0 M0
IIB. T4a N0 M0 IIIC. T4b N0 M0 |
|
|
Stage IV rectal adenocarcinoma
|
IVA. M1a
IVB. M1b |
|
|
T1 rectal adenocarcinoma
|
Tumor invades submucosa of rectum
|
|
|
T2 rectal adenocarcinoma
|
Tumor Invades muscularis propria
|
|
|
T3 rectal adenocarcinoma
|
Tumor invades through muscularis propria and into pericolorectal tissues
|
|
|
T4 rectal adenocarcinoma
|
T4a. tumor penetrates surface of visceral peritoneum
T4b. tumor directly invades or is adherent to other organs( e.g. prostate, seminal vesicles, cervix, vagina) |
|
|
Tis rectal adenocarcinoma
|
Carcinoma in situ, intraepithelial or invasion of lamina propria.
|
|
|
N2b rectal adenocarcinoma
|
metastasis to 7 or more regional lymph nodes
|
|
|
N2a rectal adenocarcinoma
|
metastasis to 4-6 regional lymph nodes
|
|
|
N1c rectal adenocarcinoma
|
tumor deposits in the subserosa, mesentery, or non-peritonealized pericolic or perirectal tissues without nodal metastasis
|
|
|
N1b rectal adenocarcinoma
|
Metastasis to 2-3 regional lymph nodes
|
|
|
N1a rectal adenocarcinoma
|
Metastasis to 1 regional lymph nodes
|
|
|
M1a rectal adenocarcinoma
|
Metastasis to one organ or site, (e.g. liver, lung, ovary, non-regional node)
|
|
|
M1b rectal adenocarcinoma
|
Metastasis to more than one organ/site or the peritoneum
|
|
|
Stage IIIA rectal adenocarcinoma
|
T1-2 N1, or T1 N2a
|
|
|
Stage IIIC rectal adenocarcinoma
|
T4a N2a
T3-4a N2b T4b N1-2 |
|
|
Stage IIIB rectal adenocarcinoma
|
T3-4a N1
T2-3 N2a T1-2 N2b |
|
|
Stage III rectal adenocarcinoma breakdown
|
IIIA
IIIB IIIC |
|
|
T1 glottic cancer
|
T1a. tumor limited to 1 true vocal cord
T1b. tumor involves both vocal cords *tumor may involve anterior or posterior commisure |
|
|
T2 glottic cancer
|
tumor extends to supraglottis or subglottis
tumor impairs vocal cord mobility |
|
|
Stage III cervix cancer breakdown
|
Stage IIIA
Stage IIIB |
|
|
Stage IIIB cervix cancer
|
Tumor extends to pelvic sidewall
Causes hydronephrosis or nonfunctioning kidney Regional lymph node metastasis |
|
|
Stage IIIA cervix cancer
|
Tumor involves lower third of the vagina
|
|
|
Stage IIB cervix cancer
|
Tumor with parametrial involvement
|
|
|
Stage IIA cervix cancer
|
Tumor extending beyond cervix, but no parametrial invasion
IIA1. Clinically visible lesion, but 4 cm or less in size IIA2. Clinically visible lesion, > 4 cm in size |
|
|
Stage IB cervix cancer
|
1B1. Tumor limited to cervical uterus, clinically visible but 4 cm or less in size
1B2. Tumor limited to cervical uterus, clinically visible and > 4 cm |
|
|
Stage IA cervix cancer
|
1A1.clinically not visible lesion, measures stromal invasion 3.0 mm or less and 7.0 mm or less in horizontal spread
1A2. Measured stromal invasion more than 3.0 mm and not more than 5.0, horizontal spread 7.0 mm or less |
|
|
Stage IVA cervix cancer
|
Tumor invades mucosa of bladder or rectum, and or extends beyond true pelvis
|
|
|
Stage IVB cervix cancer
|
Distant metastasis including peritoneal spread, supraclavicular, mediastinal, paraaortic lymph nodes, lung liver or bone
|
|
|
T3 prostatic adenocarcinoma
|
T3a. Extracapsular extension
T3b. tumor invades into seminal vesicles. |
|
|
Stage I Nasopharynx cancer
|
T1 N0
|
|
|
Stage II Nasopharynx cancer
|
T1 N1
T2 N1 T2 N0 |
|
|
Stage III Nasopharynx cancer
|
T1-3 N2
T3 N0 T3 N1 |
|
|
Stage IVA Nasopharynx cancer
|
T4 N0
T4 N1 T4 N2 |
|
|
Stage IVB Nasopharynx cancer
|
Any T, N3 M0
|
|
|
T1 Subglottic cancer
|
Tumor limited to subglottis
|
|
|
T2 Subglottic cancer
|
Tumor extends to vocal cords with normal or impaired mobility
|
|
|
T3 Subglottic cancer
|
Tumor limited to larynx with vocal cord fixation
|
|
|
T4a Subglottic cancer
|
Moderately advanced disease with disease invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g. trachea, soft tissues or the neck including extrinsic tongue muscles, strap muscles, thyroid, esophagus).
|
|
|
T4b Subglottic cancer
|
Very advanced disease, tumor invades prevertebral space, encases carotid, or invades mediastinal structures
|
|
|
T4b Supraglottic cancer
|
tumor invades prevertebral space, encases carotid artery or invades mediastinal structures
|
|
|
T4b Glottic cancer
|
tumor invades prevertebral space, encases carotid artery or invades mediastinal structures
|
|
|
T3 Supaglottic cancer
|
Tumor limited to larynx with vocal cord fixation and/or invading post cricoid area, preepiglottic space, paraglottic space, inner cortex of thyroid cartilage
|
|
|
T4a Glottic cancer
|
Tumor invades through thyroid cartilage, and or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, esophagus)
|
|
|
T4a Supraglottic cancer
|
Tumor invades through thyroid cartilage, and or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscles of the tongue, strap muscles, thyroid, esophagus)
|
|
|
N3 for larynx, hypopharynx, oropharynx, major salivary gland, nasal cavity or paranasal sinus
|
Nodal metastasis > 6 cm
|
|
|
N2c for larynx, hypopharynx, oropharynx, major salivary gland, nasal cavity or paranasal sinus
|
Nodal metastasis to bilateral or contralateral neck nodes, but none > 6 cm
|
|
|
N2a for larynx, hypopharynx, oropharynx, major salivary gland, nasal cavity or paranasal sinus
|
Nodal metastasis to a single node that is greater than 3 cm but 6 cm or less in size
|
|
|
N2b for larynx, hypopharynx, oropharynx, major salivary gland, nasal cavity or paranasal sinus
|
Nodal metastasis to multiple ipsilateral lymph nodes, none > 6 cm
|
|
|
N1 for larynx, hypopharynx, oropharynx, major salivary gland, nasal cavity or paranasal sinus
|
Nodal metastasis 3 cm or less in size
|
|
|
T4 Non-small cell lung cancer
|
Tumor of any size that invades any of the following structures: mediastinum, esophagus, vertebrae, heart, great vessels, trachea, recurrent laryngeal, carina, separate tumor nodule in ipsilateral but different lobe
|
|
|
T3 Non-small cell lung cancer
|
Tumor > 7 cm, or one that directly invades parietal pleura, chest wall, superior sulcus tumors, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, mainstem bronchus within 2 cm of carina, associated atelectasis or obstructive pneumonitis of entire lung or separate tumor nodule in same lobe.
|
|
|
T2 Non-small cell lung cancer
|
T2a: Tumor more than 3 cm but 5 cm or less
T2b: Tumor more than 5 cm but 7 cm or less. Can involve mainstem bronchus, 2 cm or more distal to carina. Invades visceral pleura, Associated with atelectasis that involves the hilar region but not the entire lung |
|
|
N2 Non-small cell lung cancer
|
Nodal metastasis in ispilateral mediastinal and/or subcarinal lymph node
|
|
|
N3 Non-small cell lung cancer
|
Nodal metastasis to contralateral mediastinal or hilar, ipslateral or contralateral scalene or supaclavicular nodal disease
|
|
|
T1 Maxillary sinus cancer
|
Tumor restricted to maxillary sinus mucosa, no bone erosion
|
|
|
T3 Glottic carcinoma
|
Tumor limited to larynx with vocal cord fixation, invasion of paraglottic space, inner cortex of the thyroid cartilage
|
|
|
T2 prostate cancer (clinical)
|
palpable tumor
T2a - tumor involves 1/2 or less of one lobe T2b - tumor involves > 1/2 of one lobe T2c - tumor involves both lobes |
|
|
T1c prostate cancer
|
Tumor identified by needle biopsy because of elevated PSA. This is tumor that is not palpable or visible by imaging.
|
|
|
T2 supraglottic cancer
|
tumor invades mucosa of more than one subsite of supaglottis, or region outside of the supraglottis (e.g. base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the vocal cords
|
|
|
Stage IIB soft tissue sarcoma
|
T2a N0 G2
T2b N0 G2 |
|
|
Stage IB soft tissue sarcoma
|
T2a N0 G1, GX
T2b N0 G1, GX |
|
|
Stage IA soft tissue sarcoma
|
T1a N0 G1, GX
T1b N0 G1, GX |
|
|
Stage IIA soft tissue sarcoma
|
T1a N0 M0 G2,3
T1b N0 M0 G2,3 |
|
|
Stage III soft tissue sarcoma
|
T2a, T2b N0, G3
Any T, Any N M1 |
|
|
Stage IV soft tissue sarcoma
|
Any T Any N, M1
|
|
|
Stage II anal squamous cell carcinoma
|
T2 N0
T3 N0 |
|
|
Stage IIIA anal squamous cell carcinoma
|
T1-3 N1 M0
T4 N0 |
|
|
Stage IIIB anal squamous cell carcinoma
|
T4 N1
Any T, N2 Any T, N3 |
|
|
Stage IV anal squamous cell carcinoma
|
Any T Any N M1
|
|
|
Stage I anal squamous cell carcinoma
|
T1 N0
|
|
|
Stage III breakdown for anal squamous cell carcinoma
|
IIIA
IIIB |
|
|
T1 anal squamous cell carcinoma
|
Tumor 2 cm or less in size
|
|
|
T2 anal squamous cell carcinoma
|
Tumor > 2 cm but 5 cm or less.
|
|
|
T3 anal squamous cell carcinoma
|
Tumor > 5 cm
|
|
|
T4 anal squamous cell carcinoma
|
Tumor of any size invading vagina, urethra, bladder
|
|
|
N3 anal squamous cell carcinoma
|
Metastasis to perirectal and inguinal nodes
Bilateral internal iliac nodes Bilteral Inguinal nodes |
|
|
N2 anal squamous cell carcnoma
|
Metastasis to unilateral internal iliac and/or inguinal lymph nodes
|
|
|
N1 anal squamous cell carcinoma
|
Metastasis to perirectal nodes
|
|
|
T3 hypopharynx cancer
|
Tumor more than 4 cm, esophageal extension, fixation of the hemilarynx
|
|
|
T1 hypopharynx cancer
|
Tumor 2 cm or less, and/or limited to one sub-site of hypophayrnx
|
|
|
pN2a Breast cancer
|
Metastasis to 4-9 axillary lymph nodes, macrometastasis in atleast one
|
|
|
pN2b Breast cancer
|
Clinically detected internal mammary nodes without axillary nodal metastasis
|
|
|
pN1b Breast cancer
|
Metastases in internal mammary nodes with micrometastasis or macrometastasis
|
|
|
pN1a Breast cancer
|
Metastasis to 1-3 axillary lymph nodes, with at least one being a macrometasis
|
|
|
pN1mi Breast cancer
|
Metastases > 0.2mm, and/or more than 200 cells but 2 mm or less in size
|
|
|
pN3c, Breast cancer
|
metastasis to ipsilateral supraclavicular nodes
|
|
|
pN3a, Breast cancer
|
metastasis to 10 or more axillary lymph node with atleast 1 deposit, > 2 mm or metastasis to Infraclavicular (level III node)
|
|
|
pN3b, Breast cancer
|
Clinically detected ipsilateral internal mammary, with 1 or more positive axillary nodes
Micrometastasis to internal mammary node with > 3 positive axillary macromets |
|
|
T4a breast cancer
|
Invasion of the chest wall, excluding invasion of the pectoralis muscle only
|
|
|
T4b Breast cancer
|
Skin ulceration
Skin ipsilateral satellite nodules Skin edema including peau d'orange of the skin, not meeting criteria for inflammatory carcinoma |
|
|
T3 Breast cancer
|
Tumor > 5 cm
|
|
|
T2 Breast cancer
|
Tumor > 2 cm, but 5 cm or less
|
|
|
T1a Breast cancer
|
Tumor > 1 mm but 0.5 cm or less in size
|
|
|
T1b Breast cancer
|
Tumor > 0.5 cm, but 1cm or less in size
|
|
|
T1c Breast cancer
|
Tumor > 1 cm but 2 cm or less in size
|
|
|
T4c Breast cancer
|
Both T4a and T4b
|
|
|
T4d Breast Cancer
|
Inflammatory carcinoma
|
|
|
Inflammatory carcinoma of the breast
|
Diffuse malignant erythema and edema (peau d'orange) of the breast.
|
|
|
Tis (DCIS)
|
Ductal carcinoma in situ
|
|
|
Tis (LCIS)
|
Lobular carcinoma in situ
|
|
|
T1mi
|
Tumor 1mm or less in size,
|
|
|
clinical N1 Breast cancer
|
Metastases to ipsilateral axillary level I,II. Movable on exam.
|
|
|
clinical N2a Breast cancer
|
Metastases to ipsilateral axillary nodes Level I, II nodes, matted (fixed) to one another or other structures
|
|
|
clinical N2b Breast cancer
|
Clinically detected internal mammary nodes, clinically negative axilla
|
|
|
clinical N3a Breast cancer
|
Metastasis to ipsilateral infraclavicular nodes
|
|
|
Stage II Bladder Cancer
|
T2a N0
T2B N0 |
|
|
Stage I Bladder Cancer
|
T1 N0
|
|
|
N3 Bladder Cancer
|
Lymph node metastasis to common iliac nodes
|
|
|
T4a Bladder cancer
|
Invades adjacent organs (e.g., prostatic stroma, seminal vesicles, uterus)
|
|
|
T4b Bladder cancer
|
Tumor invades pelvic wall, abdominal wall
|
|
|
pT3a Bladder cancer
|
Tumor microscopically demonstrating perivesicular invasion
|
|
|
pT3b Bladder cancer
|
Tumor macroscopically demonstrating perivesicular invasion
|
|
|
Stage IV Bladder cancer
|
T4b N0
Any T N1-3 Any T Any N M1 |
|
|
Stage III Bladder Cancer
|
T3a N0
T3b N0 T4a N0 |
|
|
Stage II Bladder Cancer
|
T2a N0
T2b N0 |
|
|
Stage I Bladder Cancer
|
T1 N0
|
|
|
N3 Bladder Cancer
|
Lymph node metastasis to common iliac nodes
|
|
|
pT2a Bladder Cancer
|
Tumor invades inner half of the muscularis propria
|
|
|
T2 Nasopharynx
|
tumor with parapharyngeal extension
|
|
|
T3 Nasopharynx
|
tumor involves bony skull base or paranasal sinus
|
|
|
T4 Nasopharynx
|
Tumor with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, extension into the infratemporal fossa/masticator space
|
|
|
T1 Nasopharynx
|
Tumor confined to nasopharynx or tumor extends to oropharynx and/or nasal cavity without parapharyngeal extension
|
|
|
N3b Nasopharynx
|
Extension of tumor to the supraclavicular fossa
|
|
|
N3a Nasopharynx cancer
|
Tumor Greater than 6 cm in size
|
|
|
Pancreatic cancer: T1
|
Tumor limited to pancreas, 2 cm or less in size
|
|
|
Pancreatic cancer: T2
|
tumor limited to pancreas, more than 2 cm in size
|
|
|
Pancreatic cancer: T3
|
Tumor extends beyond the pancreas but without involvement of the celiac axis or the SMA
|
|
|
Pancreatic cancer: T4
|
Tumor involves the celiac axis or the SMA
|
|
|
Pancreatic cancer: N1
|
Positive for regional lymph node disease
|
|
|
Pancreatic cancer: Stage IA
|
T1 N0
|
|
|
Pancreatic cancer: Stage IB
|
T2 N0
|
|
|
Pancreatic cancer: Stage IIA
|
T3 N0
|
|
|
Pancreatic cancer: Stage IIB
|
T1 N1
T2 N1 T3 N1 |
|
|
Pancreatic cancer: Stage III
|
T4 Any N
|
|
|
Pancreatic carcinoma: Stage IV
|
Any T, Any N, M1
|
|
|
Oral Cavity carcinoma: T1
|
Tumor 2 cm or less in size
|
|
|
Oral cavity carcinoma: T2
|
Tumor more than 2 cm but 4 cm or less in size
|
|
|
Oral cavity: T3
|
Tumor more than 4 cm in size
|
|
|
Oral cavity carcinoma: T4a
|
Tumor invades through cortical bone, inferior alveloar nerve, floor of mouth, skin of face, deep extrinsic muscles of tongue, maxillary sinus
|
|
|
Oral cavity carcinoma: T4b
|
Tumor invades masticator space, pterygoid plates, skull base, encase carotid artery
|
|
|
Oral Cavity Carcinoma: Stage I
|
T1 N0
|
|
|
Oral cavity carcinoma: Stage II
|
T2 N0
|
|
|
Oral cavity carcinoma: Stage III
|
T3 N0
T1 N1 T2 N1 T3 N1 |
|
|
Oral cavity carcinoma: Stage IVA
|
T4a N0
T4a N1 T1 N1 T2 N2 T3 N2 T4a N2 |
|
|
Oral Cavity carcinoma: Stage IVB
|
Any T, N3
T4b, Any N |
|
|
Oral cavity carcinoma: Stage IVC
|
Any T, Any N, M1
|
|
|
Non-small cell lung cancer: Stage IA
|
T1a N0
T1b N0 |
|
|
Non-small cell lung cancer: Stage IB
|
T2a N0
|
|
|
Non-small cell lung cancer: Stage IIA
|
T2b N0
T1a N1 T1b N1 T2a N1 |
|
|
Non-small cell lung cancer: Stage IIB
|
T2b N1
T3 N0 |
|
|
Non-small cell lung cancer: Stage IIIA
|
T1a N2
T1b N2 T2a N2 T2b N2 T3 N1 T3 N2 T4 N0 T4 N1 |
|
|
Non-small cell lung cancer: Stage IIIB
|
T1a N3
T1b N3 T2a N3 T2b N3 T3 N3 T4 N3 T4 N2 |
|
|
Non-small cell lung cancer: Stage IV
|
Any T, Any N, M1a
Any T, Any N, M1b |
|
|
Hypopharynx: T4a
|
Moderately advanced: invades thyroid or cricoid cartilage, hyoid bone, thyroid gland, central compartment soft tissue
|
|
|
Hypopharynx cancer: T2
|
Tumor invades more than one subsite of the hypopharynx and/measures more than 2 cm in size but 4 cm or less, without fixation of the hemilarynx
|
|
|
Hypopharynx cancer: T4a
|
Moderately advanced disease, tumor invades the thyroid or cricoid cartilage, hyoid bone, thyroid gland, or central compartment soft tissue.
|
|
|
Oropharynx cancer: T1
|
Tumor 2 cm or less in size
|
|
|
Oropharynx cancer: T2
|
Tumor more than 2 cm but 4 cm or less in size
|
|
|
Oropharynx cancer: T3
|
Tumor more than 4 cm in greatest dimension or extension on the lingual surface of the epiglottis
|
|
|
Oropharynx cancer: T4a
|
Moderately advanced disease, tumor invades the larynx, extrinsic muscles of the tongue, medial pterygoid, hard palate, mandible
|
|
|
Oropharynx cancer: T4b
|
Very advanced disease, tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, skull base or encasement of the carotid artery
|
|
|
Nasopharynx cancer: N2
|
Bilateral metastasis on cervical LN, 6 cm or less in size
|
|
|
Nasopharynx cancer: N3b
|
Node within supraclavicular fossa
|
|
|
Nasopharynx cancer: N3a
|
Node greater than 6 cm in size
|
|
|
Nasopharynx cancer: N1
|
Unilateral metastasis in cervical LN, 6 cm or less in size, above the SCL fossa
Unilateral or bilateral retropharyngeal nodes, 6 cm or less in size |
|
|
Oropharynx cancer: Stage I
|
T1 N0
|
|
|
Oropharynx cancer: Stage II
|
T2 N0
|
|
|
Oropharynx cancer: Stage III
|
T3 N0
T1 N1 T2 N1 T3 N1 |
|
|
Oropharynx cancer: Stage IVA
|
T4a N0
T4a N1 T1 N2 T2 N2 T3 N2 T4a N2 |
|
|
Oropharynx cancer: Stage IVB
|
T4b Any N
Any T N3 |
|
|
Oropharynx cancer: Stage IVC
|
Any T, Any N, M1
|
|
|
Hypopharynx cancer: I
|
T1 N0
|
|
|
Hypopharynx cancer: II
|
T2 N0
|
|
|
Hypopharynx cancer: III
|
T3 N0
T3 N1 T2 N1 T1 N1 |
|
|
Ampullary Cancer: T1
|
Tumor limited to ampulla of vater or sphincter of oddi
|
|
|
Ampullary Cancer: T2
|
Tumor invades duodenal wall
|
|
|
Ampullary Cancer: T3
|
Tumor invades pancreas
|
|
|
Ampullary Cancer: T4
|
Tumor invades peripancreatic soft tissues or other adjacent organs or structures
|
|
|
Ampullary Cancer: N1
|
Regional lymph node metastasis
|
|
|
Ampullary Cancer: Stage IA
|
T1 N0
|
|
|
Ampullary Cancer: Stage IIA
|
T3 N0
|
|
|
Ampullary Cancer: Stage IIB
|
T1 N1
T2 N1 T3 N1 |
|
|
Ampullary Cancer: Stage III
|
T4 Any N
|
|
|
Ampullary Cancer: Stage IV
|
Any T, Any N, M1
|
|
|
Ampullary Cancer: IB
|
T2 N0
|
|
|
Thyroid carcinoma: T3
|
Tumor > 4 cm in size but limited to thyroid, or any tumor with minimal extathyroidal extension (sternothyroid, perithyroid)
|
|
|
Thyroid carcinoma: T2
|
Tumor > 2 cm but 4 cm or less in size
|
|
|
Thyroid carcinoma: T1a
|
Tumor 1 cm or less in size, limited to thyroid
|
|
|
Thyroid carcinoma: T1b
|
Tumor more than 1 cm, but 2 cm or less and limited to thyroid
|
|
|
Renal cell carcinoma: T4
|
Tumor invades beyond gerota's fascia, including contiguous extension into the ipsilateral adrenal gland
|
|
|
Renal cell carcinoma: T3c
|
Tumor grossly extends into the vena cava above the diaphragm or invades the wall of the vena cava
|
|
|
Renal cell carcinoma: T3b
|
Tumor grossly extends into the vena cava below the level of the diaphragm
|
|
|
Renal cell carcinoma: T3a
|
Tumor extends grossly into the renal vein or its segmental branches or tumor invades perirenal and/or renal sinus fat but not beyond Gerota's fascia
|
|
|
Renal cell carcinoma: T2a
|
Tumor > 7 cm but 10 cm or less and limited to kidney
|
|
|
Renal cell carcinoma: T2b
|
Tumor greater than 10 cm but limited to kidney
|
|
|
Renal cell carcinoma: T1a
|
Tumor is 4 cm or less in size, limited to kidney
|
|
|
Renal cell carcinoma: T1b
|
Tumor is more than 4 cm but 7 cm or less in size
|
|
|
Renal cell carcinoma: N1
|
Metastasis in regional lymph nodes
|
|
|
Renal cell carcinoma: M1
|
Distant metastasis
|
|
|
Renal cell carcinoma: Stage I
|
T1 N0
|
|
|
Renal cell carcinoma: Stage II
|
T2 N0
|
|
|
Renal cell carcinoma: Stage IV
|
T4 N0
Any T Any N, M1 |
|
|
Renal cell carcinoma: Stage III
|
T1 N1
T2 N1 T3 N0 T3 N1 |
|
|
Non-small cell lung cancer: Stage IA
|
T1a N0
T1b N0 |
|
|
Non-small cell lung cancer: Stage IB
|
T2a N0
|
|
|
Non-small cell lung cancer: Stage IIA
|
T2b N)
T1a N1 T1b N1 T2a N1 |
|
|
Non-small cell lung cancer: Stage IIB
|
T2b N1
T3 N0 |
|
|
Non-small cell lung cancer: Stage IIIA
|
T1-3 N2
T3 N1 T4 N0 T4 N1 |
|
|
Non-small cell lung cancer: Stage IIIA
|
T4 N2
T1-T4 N3 |
|
|
Non-small cell lung cancer: Stage IV
|
Any T Any N, M1a or M1b
|
|
|
Non-small cell lung cancer: T1a
|
Tumor < 2 cm, no visceral pleura invasion, no MSB invasion
|
|
|
Non-small cell lung cancer: T1b
|
Tumor > 2 cm but 3 cm or less, no visceral pleural invasion and not MSB invasion
|
